Skip to content

Drug interactions

Clomipramine + Talquetamab

Severity: Moderate

Clomipramine and Talquetamab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cytokine release syndrome after talquetamab can transiently suppress CYP enzyme activity, which may raise concentrations of CYP substrates such as clomipramine. Higher clomipramine levels could increase anticholinergic, sedative and cardiac toxicity.

What this interaction means in plain words

Clomipramine and Talquetamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Clomipramine belongs to Central Nervous System; Talquetamab belongs to Oncology.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP enzymes (including CYP1A2) reduces clomipramine metabolism.

What to do

Monitor for clomipramine toxicity, including sedation, anticholinergic effects and arrhythmia, from the start of step-up dosing through about two weeks after the first treatment dose and during any CRS. Reduce the clomipramine dose if toxicity appears.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Clomipramine and Talquetamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Clomipramine with Talquetamab?

MediHelp rates the interaction as moderate. Clomipramine and Talquetamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cytokine release syndrome after talquetamab can transiently suppress CYP enzyme activity, which may raise concentrations of CYP substrates such as clomipramine. Higher clomipramine levels could increase anticholinergic, sedative and cardiac toxicity.

How serious is the interaction between Clomipramine and Talquetamab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for clomipramine toxicity, including sedation, anticholinergic effects and arrhythmia, from the start of step-up dosing through about two weeks after the first treatment dose and during any CRS. Reduce the clomipramine dose if toxicity appears.

What other medicines interact with Clomipramine?

MediHelp also lists interactions of Clomipramine with, for example, Arsenic trioxide, Dofetilide, Droperidol. The full list is on the Clomipramine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in